The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
Sphingosine 1-Phosphate Receptor Signaling
Abstract
The sphingosine 1-phosphate (S1P) receptor signaling system is a productive model system. A hydrophobic zwitterionic lysophospholipid ligand with difficult physical properties interacts with five high-affinity G protein–coupled receptors to generate multiple downstream signals. These signals modulate homeostasis and pathology on a steep agonist concentration-response curve. Ligand presence is essential for vascular development and endothelial integrity, while acute increases in ligand concentrations result in cardiac death. Understanding this integrated biochemical system has exemplified the impact of both genetics and chemistry. Developing specific tools with defined biochemical properties for the reversible modulation of signals in real time has been essential to complement insights gained from genetic approaches that may be irreversible and compensated. Despite its knife-edge between life and death, this system, based in part on receptor subtype-selectivity and in part on differential attenuation of deleterious signals, now appears to be on the cusp of meaningful therapy for multiple sclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Early studies of primary bile acids have been shown to exert direct negative myocardial chronotropic effects in a dose-dependent fashion132,133.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [132]
In the citing paper
“Though at lower concentrations relative to primary bile acids even in cholestatic states, secondary bile acids can also exert similar effects.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [132]
Citations
Cites
Principles of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,411
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H., Kühn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,280
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
Sphingosine-1-phosphate: an enigmatic signalling lipid
Spiegel, S., & Milstien, S. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1103 · Cited by 2,115
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
MANDALA, S. M., Hajdu, R., Bergstrom, J. D., Quackenbush, E. J., Xie, J., Milligan, J. A., Thornton, R. A., Shei, G.-J., Card, D., Keohane, C.-A., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,691
Self-citationThe Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E. E., Baumruker, T., HIESTAND, P. C., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200176200 · Cited by 1,512
GPCR Engineering Yields High-Resolution Structural Insights into β 2 -Adrenergic Receptor Function
Rosenbaum, D. M., Cherezov, V., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H., Yao, X.-J., Weis, W. I., Stevens, R. C., et al. (2007) · Science · doi:10.1126/science.1150609 · Cited by 1,335
CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
Shiow, L. R., Rosen, D. B., Brdičková, N., Xu, Y., An, J., Lanier, L. L., Cyster, J. G., & Matloubian, M. (2006) · Nature · doi:10.1038/nature04606 · Cited by 1,189
Liu, Y., Wada, R., Yamashita, T., Mi, Y., Deng, C., Hobson, J. P., Rosenfeldt, H. M., Nava, V. E., Chae, S.-S., Lee, M.-J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10905 · Cited by 1,165
Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
Kappos, L., Antel, J. P., Comi, G., Montalbán, X., O'Connor, P. W., Polman, C. H., Haas, T., Korn, A., Karlsson, G., & Radue, E. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052643 · Cited by 1,058
Research works printed but not linked: 6
- Clair T, 2003, Cancer Res., 63, 5446
- 10.1042/0264-6021:3520809 · DOI
- Chiba K, 2006, Cell Mol. Immunol., 3, 11
- Suzuki S, 1998, Transplant. Int., 11, 95
- Suzuki S, 1996, Transplant. Proc., 28, 2049
- Merrill AH, 2007, Naunyn-Schmiedebergs Arch. Pharmacol., 374, 321
Cited by
Sorted by citations
Items 101–200 of 424
Modulators of the Sphingosine 1-phosphate receptor 1
Urbano, M., Guerrero, M. A., Rosen, H., & Roberts, E. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.09.058 · Cited by 59
Self-citationSafarian, F., Khallaghi, B., Ahmadiani, A., & Dargahi, L. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0478-1 · Cited by 58
Adyshev, D. M., Moldobaeva, N., Elangovan, V. R., Garcia, J. G. N., & Dudek, S. M. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.08.003 · Cited by 58
Cavone, L., Felici, R., Lapucci, A., Buonvicino, D., Pratesi, S., Muzzi, M., Hakiki, B., Maggi, L., Peruzzi, B., Caporale, R., et al. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.06.019 · Cited by 58
Therapeutic Potential of Targeting SK1 in Human Cancers
Alshaker, H. A., Sauer, L., Monteil, D. C., Ottaviani, S., Srivats, S., Böhler, T., & Pchejetski, D. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-394274-6.00006-6 · Cited by 62
Marfia, G., Campanella, R., Navone, S. E., Vito, C. D., Riccitelli, E., Hadi, L. A., Bornati, A., de Rezende, G., Giussani, P., Tringali, C., et al. (2014) · Glia · doi:10.1002/glia.22718 · Cited by 57
Extracellular and intracellular sphingosine-1-phosphate in cancer
Yester, J., Tizazu, E., Harikumar, K. B., & Kordula, T. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9305-0 · Cited by 58
Increased sphingosine-1-phosphate improves muscle regeneration in acutely injured mdx mice
Ieronimakis, N. M., Pantoja, M., Hays, A. L., Dosey, T. L., Qi, J., Fischer, K. A., Hoofnagle, A. N., Sadı́lek, M., Chamberlain, J. S., Ruohola‐Baker, H., et al. (2013) · Skeletal Muscle · doi:10.1186/2044-5040-3-20 · Cited by 57
Okamoto, M., Tsukamoto, H., Kouwaki, T., Seya, T., & Oshiumi, H. (2017) · Viral Immunology · doi:10.1089/vim.2016.0178 · Cited by 58
Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P1 and S1P5
Cee, V. J., Frohn, M., Lanman, B. A., Golden, J. E., Muller, K. M., Neira, S., Pickrell, A., Arnett, H. A., Buys, J., Gore, A., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100306h · Cited by 55
Berdyshev, E. V., Gorshkova, I. A., Usatyuk, P. V., Kalari, S. K., Zhao, Y., Pyne, N. J., Pyne, S., Sabbadini, R. A., Garcia, J. G. N., & Natarajan, V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016571 · Cited by 54
Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection
Oldstone, M. B. A., Teijaro, J. R., Walsh, K. B., & Rosen, H. (2012) · Virology · doi:10.1016/j.virol.2012.09.039 · Cited by 57
Self-citationFunctional Selectivity in Serotonin Receptor 2A (5-HT2A) Endocytosis, Recycling, and Phosphorylation
Raote, I., Bhattacharyya, S., & Panicker, M. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.078626 · Cited by 57
Norman, B. H., & McDermott, J. S. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00964 · Cited by 52
Sassoli, C., Pierucci, F., Zecchi‐Orlandini, S., & Meacci, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225545 · Cited by 55
A ménage à trois made in heaven: G-protein-coupled receptors, lipids and TRP channels
Kukkonen, J. P. (2011) · Cell Calcium · doi:10.1016/j.ceca.2011.04.005 · Cited by 52
Ross, J. S., Hu, W. M., Rosen, B. P., Snider, A. J., Obeid, L. M., & Cowart, L. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.477786 · Cited by 58
The adipokine/ceramide axis: Key aspects of insulin sensitization
Xia, J. Y., Morley, T. S., & Scherer, P. E. (2013) · Biochimie · doi:10.1016/j.biochi.2013.08.013 · Cited by 52
Lee, M., Hammad, S. M., Semler, A. J., Luttrell, L. M., Lopes-Virella, M. F., & Klein, R. L. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m003988 · Cited by 51
Li, C., Li, J.-N., Kays, J. S., Guerrero, M. A., & Nicol, G. D. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0286-8 · Cited by 51
Cortical Actin Dynamics in Endothelial Permeability
Belvitch, P. G., Htwe, Y. M., Brown, M. E., & Dudek, S. M. (2018) · Current topics in membranes · doi:10.1016/bs.ctm.2018.09.003 · Cited by 54
Du, J., Zeng, C., Li, Q., Chen, B., Liu, H., Huang, X., & Huang, Q. (2012) · Pathology - Research and Practice · doi:10.1016/j.prp.2011.11.008 · Cited by 49
Sphingosine 1-phosphate receptor-1 in cardiomyocytes is required for normal cardiac development
Clay, H., Wilsbacher, L. D., Wilson, S. J., Duong, D. N., McDonald, M., Lam, I., Park, K. E., Chun, J. J. M., & Coughlin, S. R. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2016.06.024 · Cited by 49
Hadi, L. A., Vito, C. D., Marfia, G., Ferraretto, A., Tringali, C., Viani, P., & Riboni, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143384 · Cited by 49
Sphingolipid-mediated calcium signaling and its pathological effects
Pulli, I., Asghar, M. Y., Kemppainen, K., & Törnquist, K. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.04.012 · Cited by 48
Chi, X. X., & Nicol, G. D. (2010) · Journal of Neurophysiology · doi:10.1152/jn.00709.2010 · Cited by 48
Billich, A., Baumruker, T., Beerli, C., Bigaud, M., Bruns, C., Calzascia, T., Isken, A., Kinzel, B., Loetscher, E., Metzler, B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059630 · Cited by 47
Re-Configuration of Sphingolipid Metabolism by Oncogenic Transformation
Don, A. S., Lim, X. Y., & Couttas, T. A. (2014) · Biomolecules · doi:10.3390/biom4010315 · Cited by 51
Hypoxia, Therapeutic Resistance, and Sphingosine 1-Phosphate
Cuvillier, O., Ader, I., Bouquerel, P., Brizuela, L., Gstalder, C., & Malavaud, B. A. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-394274-6.00005-4 · Cited by 47
Dynamin 2–dependent endocytosis is required for sustained S1PR1 signaling
Willinger, T., Ferguson, S. M., Pereira, J. P., Camilli, P. V. D., & Flavell, R. A. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131343 · Cited by 47
Im, D. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.135 · Cited by 46
Childress, E. S., Kharel, Y., Brown, A. M., Bevan, D. R., Lynch, K. R., & Santos, W. L. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00233 · Cited by 46
The role of sphingosine-1-phosphate in autophagy and related disorders
Xiao, S., Peng, K., Li, C.-L., Long, Y., & Yu, Q. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01681-x · Cited by 49
Verzijl, D., Peters, S. L. M., & Alewijnse, A. E. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0041-z · Cited by 45
Brana, C., Frossard, M., Gobert, R. P., Martinier, N., Boschert, U., & Seabrook, T. J. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12048 · Cited by 45
Neuronal sphingosine kinase 2 subcellular localization is altered in Alzheimer’s disease brain
Dominguez, G., Maddelein, M.-L., Pucelle, M., Nicaise, Y., Maurage, C.-A., Duyckaerts, C., Cuvillier, O., & Delisle, M.-B. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0527-z · Cited by 43
S1P-S1PR1 Signaling: the “Sphinx” in Osteoimmunology
Xiao, L., Zhou, Y., Friis, T., Beagley, K. W., & Xiao, Y. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01409 · Cited by 47
Bergelin, N., Löf, C., Balthasar, S., Kalhori, V., & Törnquist, K. (2010) · Endocrinology · doi:10.1210/en.2009-1387 · Cited by 45
Breaking through the therapeutic ceiling of inflammatory bowel disease: Dual-targeted therapies
Feng, Z., Kang, G., Wang, J., Gao, X., Wang, X., Ye, Y., Liu, L., Zhao, J., Liu, X., Huang, H., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114174 · Cited by 46
Tatematsu, S., Francis, S. A., Natarajan, P., Rader, D. J., Saghatelian, A., Brown, J. D., Michel, T. M., & Plutzky, J. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301300 · Cited by 45
Ligand chain length drives activation of lipid G protein-coupled receptors
Troupiotis-Tsaïlaki, A., Zachmann, J., González-Gil, I., González, Á., Ortega‐Gutiérrez, S., López-Rodríguez, M. L., Pardo, L., & Govaerts, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-02104-5 · Cited by 45
Badawy, S. M. M., Okada, T., Kajimoto, T., Hirase, M., Matovelo, S. A., Nakamura, S., Yoshida, D., Ijuin, T., & Nakamura, S. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001986 · Cited by 44
Nejad, L. D., Stumpe, M., Rauch, M., Hemphill, A. F., Schneiter, R., Bütikofer, P., & Serricchio, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-65248-x · Cited by 43
Post-translational regulation of sphingosine kinases
Chan, H., & Pitson, S. M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.07.005 · Cited by 44
Gardner, N. M., Riley, R. T., Showker, J. L., Voss, K. A., Sachs, A. J., Maddox, J. R., & Waes, J. B. G. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.02.018 · Cited by 44
Paz, N. G. D., Melchior, B., & Frangos, J. A. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00148.2016 · Cited by 44
Martínez‐Vieyra, I., Rodríguez‐Varela, M., García-Rubio, D., la Mora-Mojica, B. D., Méndez‐Méndez, J. V., Durán–Álvarez, J. C., & Cerecedo, D. (2019) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2019.05.018 · Cited by 42
A New Shield for a Cytokine Storm
Iwasaki, A., & Medzhitov, R. M. (2011) · Cell · doi:10.1016/j.cell.2011.08.027 · Cited by 42
Role for peroxynitrite in sphingosine-1-phosphate-induced hyperalgesia in rats
Doyle, T. M., Finley, A., Chen, Z., & Salvemini, D. (2011) · Pain · doi:10.1016/j.pain.2010.12.011 · Cited by 39
Sphingosine-1-phosphate receptors as emerging targets for treatment of pain
Welch, S. P., Sim‐Selley, L. J., & Selley, D. E. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.08.010 · Cited by 40
Hurst, D. P., Schmeisser, M. G., & Reggio, P. H. (2013) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2013.01.009 · Cited by 42
A Comprehensive High-Resolution Targeted Workflow for the Deep Profiling of Sphingolipids
Peng, B., Weintraub, S. T., Coman, C., Ponnaiyan, S., Sharma, R. K., Tews, B., Winter, D., & Ahrends, R. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b03576 · Cited by 40
The Lysophosphatidylserines—An Emerging Class of Signalling Lysophospholipids
Shanbhag, K., Mhetre, A. B., Khandelwal, N., & Kamat, S. S. (2020) · The Journal of Membrane Biology · doi:10.1007/s00232-020-00133-2 · Cited by 40
Wang, T., Zhang, H., Han, Y., Zheng, Q. Y., Liu, H., Han, M., & Li, Z. (2023) · Advanced Science · doi:10.1002/advs.202204961 · Cited by 39
Ogle, M. E., Olingy, C. E., Awojoodu, A. O., Das, A., Ortiz, R. A., Cheung, H. Y., & Botchwey, E. A. (2016) · Stem Cells · doi:10.1002/stem.2556 · Cited by 39
Li, C., Wu, B., Li, Y., Liu, Y., Wang, J., Xie, J., Xu, X., Tian, X., Ye, Z., Guan, J., et al. (2022) · Blood · doi:10.1182/blood.2022016112 · Cited by 42
Ingham, N. J., Carlisle, F. A., Pearson, S. A., Lewis, M. A., Buniello, A., Chen, J., Isaacson, R. L., Pass, J. C., White, J. K., Dawson, S. J., et al. (2016) · Scientific Reports · doi:10.1038/srep28964 · Cited by 37
A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models
Jin, J., Xue, N., Liu, Y., Fu, R., Wang, M., Ji, M., Lai, F., Hu, J., Wang, X., Xiao, Q., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.11.006 · Cited by 41
Cytoskeletal Dynamics and Lung Fluid Balance
Vogel, S. M., & Malik, A. B. (2012) · Comprehensive physiology · doi:10.1002/cphy.c100006 · Cited by 41
Genetic elevation of Sphingosine 1-phosphate suppresses dystrophic muscle phenotypes in Drosophila
Pantoja, M., Fischer, K. A., Ieronimakis, N. M., Reyes, M., & Ruohola‐Baker, H. (2012) · Development · doi:10.1242/dev.087791 · Cited by 36
Oldstone, M. B. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222025110 · Cited by 38
Chiricozzi, E., Loberto, N., Schiumarini, D., Samarani, M., Mancini, G., Tamanini, A., Lippi, G., Dechecchi, M. C., Bassi, R., Giussani, P., et al. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0717-269r · Cited by 37
Targeting Sphingosine-1-Phosphate Receptors in Cancer
Watters, R. J., Wang, H., Sung, S., Loughran, T. P., & Liu, X. (2011) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152011797655041 · Cited by 35
Drosophila melanogaster as a Model of Muscle Degeneration Disorders
Kreipke, R. E., Kwon, Y. V., Shcherbata, H. R., & Ruohola‐Baker, H. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.07.003 · Cited by 36
Chatzikonstantinou, S., Poulidou, V., Arnaoutoglou, M., Kazis, D. A., Heliopoulos, I., Grigoriadis, N., & Boziki, M. K. (2021) · Cells · doi:10.3390/cells10113217 · Cited by 35
Bile acids and sphingolipids in non-alcoholic fatty liver disease
Jackson, K. G., Way, G. W., & Zhou, H. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002156 · Cited by 36
Melanoma Occurring During Treatment With Fingolimod for Multiple Sclerosis: A Case Report
Conzett, K. B. (2011) · Archives of Dermatology · doi:10.1001/archdermatol.2011.212 · Cited by 36
S1P2 receptor regulation of sphingosine-1-phosphate effects on conventional outflow physiology
Sumida, G. M., & Stamer, W. D. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00437.2010 · Cited by 36
Zhao, J., Zhu, M., Jiang, H., Shen, S., Su, X., & Shi, Y. P. (2019) · Scientific Reports · doi:10.1038/s41598-019-41760-7 · Cited by 35
RetractedSphingosine 1-Phosphate Receptors in Cerebral Ischemia
Gaire, B. P., & Choi, J. W. (2020) · NeuroMolecular Medicine · doi:10.1007/s12017-020-08614-2 · Cited by 35
Cardiovascular Effects of Sphingosine-1-Phosphate (S1P)
Levkau, B. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-7091-1511-4_8 · Cited by 35
Sphingolipid transfer proteins defined by the GLTP-fold
Malinina, L. V., Simanshu, D. K., Zhai, X., Самыгина, В. Р., Kamlekar, R. K., Kenoth, R., Ochoa-Lizarralde, B., Malakhova, M. L., Molotkovsky, J. G., Patel, D. J., et al. (2015) · Quarterly Reviews of Biophysics · doi:10.1017/s003358351400016x · Cited by 34
Sumida, G. M., & Stamer, W. D. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5391 · Cited by 34
Andrieu, G. P., Ledoux, A., Branka, S., Bocquet, M., Gilhodes, J., Walzer, T., Kasahara, K., Inagaki, M., Sabbadini, R. A., Cuvillier, O., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aah4007 · Cited by 35
Sphingolipid Metabolism and Analysis in Metabolic Disease
Brice, S. E., & Cowart, L. A. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0650-1_1 · Cited by 35
García-Pacios, M., Collado, M. I., Busto, J. V., Sot, J., Alonso, A., Arrondo, J.-L. R., & Goñi, F. M. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.07.001 · Cited by 34
Sphingosine-1-phosphate receptor 3 influences cell cycle progression in muscle satellite cells
Fortier, M., Figeac, N., White, R. B., Knopp, P., & Zammit, P. S. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.07.006 · Cited by 34
Becker, S., von Otte, S., Robenek, H., Diedrich, K., & Nofer, J. (2010) · Biology of Reproduction · doi:10.1095/biolreprod.110.084152 · Cited by 34
Post-translational modifications of S1PR1 and endothelial barrier regulation
Anwar, M., & Mehta, D. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158760 · Cited by 34
Recent advances in the management of systemic lupus erythematosus
Sciascia, S., Radin, M., Roccatello, D., Sanna, G., & Bertolaccini, M. L. (2018) · F1000Research · doi:10.12688/f1000research.13941.1 · Cited by 33
Kays, J. S., Li, C., & Nicol, G. D. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00053.2012 · Cited by 31
Mapping Protein Targets of Bioactive Small Molecules Using Lipid-Based Chemical Proteomics
Lum, K. M., Sato, Y., Beyer, B. A., Plaisted, W. C., Anglin, J. L., Lairson, L. L., & Cravatt, B. F. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00581 · Cited by 31
Ma, H., Wang, H., Tian, F., Zhong, Y., Liu, Z., & Liao, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00438 · Cited by 31
Hatziapostolou, M., Κούκος, Γ., Polytarchou, C., Kottakis, F., Serebrennikova, O. B., Kuliopulos, A., & Tsichlis, P. N. (2011) · Science Signaling · doi:10.1126/scisignal.2002006 · Cited by 34
Ohotski, J., Rosen, H., Bittman, R., Pyne, S., & Pyne, N. J. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.01.023 · Cited by 30
Self-citationWill novel oral formulations change the management of inflammatory bowel disease?
Nielsen, O. H., Seidelin, J. B., Ainsworth, M. A., & Coskun, M. (2016) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1165204 · Cited by 30
Wang, F., & Wu, Z. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6086 · Cited by 30
Regulation of cancer cell migration and invasion by sphingosine-1-phosphate
Brocklyn, J. R. V. (2010) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v1.i10.307 · Cited by 30
Moberly, J. B., Ford, D. M., Zahir, H., Chen, S., Mochizuki, T., Truitt, K. E., & Vollmer, T. L. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.03.007 · Cited by 30
LeBlanc, F., Liu, X., Hengst, J. A., Fox, T. E., Calvert, V. S., Petricoin, E. F., Yun, J. K., Feith, D. J., & Loughran, T. P. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1078949 · Cited by 31
The Sphingolipid Rheostat: A Potential Target for Improving Pancreatic Islet Survival and Function
Jessup, C. F., Bonder, C. S., Pitson, S. M., & Coates, P. T. (2011) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153011797881201 · Cited by 30
The SphKs/S1P/S1PR1 axis in immunity and cancer: more ore to be mined
Jin, L., Liu, W.-R., Tian, M., Fan, J., & Shi, Y. (2016) · World Journal of Surgical Oncology · doi:10.1186/s12957-016-0884-7 · Cited by 31
Janus Kinase Antagonists and Other Novel Small Molecules for the Treatment of Crohn's Disease
Boland, B. S., & Vermeire, S. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.05.015 · Cited by 29
Okrzeja, J., Karwowska, A., & Błachnio-Zabielska, A. U. (2022) · Nutrients · doi:10.3390/nu14122438 · Cited by 29
Asle‐Rousta, M., Kolahdooz, Z., Dargahi, L., Ahmadiani, A., & Nasoohi, S. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0423-3 · Cited by 29
Bazzazi, H., & Popel, A. S. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005332 · Cited by 30
Karuppuchamy, T., Tyler, C. J., Lundborg, L. R., Pérez-Jeldres, T., Kimball, A. K., Clambey, E. T., Jedlicka, P., & Rivera–Nieves, J. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz174 · Cited by 30
Morris, A. J., Selim, S., Salous, A. K., & Smyth, S. S. (2009) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2009.07.005 · Cited by 28
Toponomics: studying protein–protein interactions and protein networks in intact tissue
Pierre, S. C., & Scholich, K. (2010) · Molecular BioSystems · doi:10.1039/b910653g · Cited by 28
Joós, G., Jákim, J., Kiss, B., Szamosi, R., Papp, T., Felszeghy, S., Sághy, T., Nagy, G., & Szondy, Z. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.02.002 · Cited by 29
Metadata
- Authors
- Rosen, H., Gonzalez-Cabrera, P. J., Sanna, M. G., & Brown, S.
- Affiliations
- Scripps Research Institute (US)
- Departments of Chemical Physiology and Immunology and The Scripps Research Institute Molecular Screening Center, The Scripps Research Institute, La Jolla, California 92037;
- Venue
- Annual Review of Biochemistry
- Publisher
- Annual Reviews
- Published
- 2009-06-01
- Volume
- 78
- Issue
- 1
- Pages
- 743-768
- ISSN
- 0066-4154 (ISSN-L)
- 1545-4509
- OpenAlex
- W2127032203
- Cited by
- 404
- References
- 151
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 8 · 2023: 10 · 2022: 12 · 2021: 19 · 2020: 17 · 2019: 18 · 2018: 29 · 2017: 27 · 2016: 28 · 2015: 21 · 2014: 27 · 2013: 48 · 2012: 50
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- sphingosine-1-phosphate, S1P receptors, G protein-coupled receptors, receptor signaling, vascular development, endothelial integrity, cardiovascular mortality, signal attenuation, receptor subtype selectivity, multiple sclerosis treatment
- MeSH terms
- Animals, Cardiovascular System, Humans, Lymphoid Tissue, Multiple Sclerosis, Signal Transduction, Receptors, Lysosphingolipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review